Yasuaki Ogawa

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

Masanori Baba, Osamu Nishimura, Naoyuki Kanzaki et al. · Proceedings of the National Academy of Sciences · 1999 · 755 citations

Medicine, Immunology, Pharmacology +17

A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.

Yasuaki Ogawa, Masaki Yamamoto, Hiroaki Okada et al. · Chemical and Pharmaceutical Bulletin · 1988 · 504 citations · Full text

Pharmacy, Bioengineering, Pharmaceutics +16

Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers

Hiroaki Okada, Yayoi Doken, Yasuaki Ogawa et al. · Pharmaceutical Research · 1994 · 205 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs

Yutaka Mizushima, Toshiyuki Ikoma, Jyunzo Tanaka et al. · Journal of Controlled Release · 2005 · 180 citations

Pharmacy, Pharmaceutics, Pharmacology +15

Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer.

Yasuaki Ogawa, Masaki Yamamoto, Shigeyuki Takada et al. · Chemical and Pharmaceutical Bulletin · 1988 · 174 citations · Full text

Pharmacy, Bioengineering, Pharmaceutics +17